Doxazosin mesylate
- Product NDC
- 62135-052
- 11-digit product format
- 621350052
- Labeler code
- 62135
- Product ID
- 62135-052_fdb507a5-0211-0689-e053-6394a90a860a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA075646
- Marketing category
- ANDA
- Marketing start
- 2000-10-18
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin mesylate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197625, 197626, 197627, 197628 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-052-90 | Doxazosin mesylate | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-052 | DOXAZOSIN MESYLATE TABLET [CHARTWELL RX, LLC] | 1 | Current NDC, 1 package rows | 20230620_a7f589b0-eebb-48cb-912f-a4bd956e4dcb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-052-90 | 62135005290 | 90 TABLET in 1 BOTTLE (62135-052-90) | 90 tablet | 2023-06-06 | No | No | Current |